Biohaven .(US:BHVN) ZACKS·2025-12-24 15:57Core Viewpoint - Biohaven Ltd. (BHVN) shares have increased by 11.6% over the past four weeks, closing at $10.5, with a mean price target of $19.8 indicating a potential upside of 88.6% according to Wall Street analysts [1] Price Targets - The average of 15 short-term price targets ranges from a low of $9.00 to a high of $50.00, with a standard deviation of $12.49, indicating variability among analysts [2] - The lowest estimate suggests a decline of 14.3% from the current price, while the highest estimate indicates a potential upside of 376.2% [2] Analyst Sentiment - Analysts show a consensus that BHVN will report better earnings than previously estimated, which supports the potential for stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 4%, with one estimate moving higher and no negative revisions [12] Zacks Rank - BHVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to concerns about analysts' biases and the accuracy of their estimates [3][10] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement, which can be a starting point for further research [9]